Several studies have indicated that bisphenol A (BPA), which is widely used in polycarbonate plastic and epoxy resin manufacturing, can disrupt normal endocrine function. Given that BPA's estrogen receptor (ER) binding and interaction are 100--1,000 times weaker than those of endogenous hormones, researchers have hypothesized that BPA interacts with nuclear receptors other than ER. A recent study directly assayed BPA's interaction with estrogen-related receptor-γ (ERR-γ), one of a family of "orphan" nuclear receptors---those for which natural ligands are unknown---and clarified the structural requirements that enable BPA to bind this receptor **\[*EHP* 116:32--38; Okada et al.\]**.

Earlier research by the same team demonstrated that BPA strongly binds ERR-γ. The research also showed that BPA preserves ERR-γ's high constitutive activity. Receptors with constitutive activity trigger molecular events in the absence of a ligand; specific ligands known as inverse agonists can deactivate these receptors.

The authors emphasize the importance of this investigation by noting that ERR-γ is very strongly expressed in the mammalian brain during development and in the brain, lung, and other tissues in adults; unpublished results from this group show the highest expression in the placenta. It is possible that BPA's binding ERR-γ could affect the receptor's role by activating transcription at the wrong times.

Using tritium-labeled BPA, the researchers conducted the first saturation binding assay to precisely characterize how strongly BPA binds ERR-γ. They also ran competitive binding assays with BPA analogs and other industrial chemicals, including phenol derivatives, to identify which structural characteristics of the chemicals are critical for binding ERR-γ and maintaining its constitutive activity. They found specific, extremely high binding affinity of BPA for ERR-γ. BPA analogs varied in their ability to bind the receptor, and phenol derivatives were newly discovered to be potential candidates for ERR-γ--mediated endocrine disruption.

These findings raise the immediate question of whether reported BPA-related endocrine disruption might actually be mediated through ERR-γ rather than through ER. Additionally, the researchers stress the need to determine the normal physiologic roles of ERR-γ as well as the ways in which BPA might affect these roles. Given the strong expression of ERR-γ in the fetal brain and placenta, further information is especially urgent with regard to outcomes for newborns.
